Molecular Medicine

, Volume 21, Issue 1, pp 233–241 | Cite as

Loss of Allograft Inflammatory Factor-1 Ameliorates Experimental Autoimmune Encephalomyelitis by Limiting Encephalitogenic CD4 T-Cell Expansion

  • Prameladevi Chinnasamy
  • Sarah E. Lutz
  • Dario F. Riascos-Bernal
  • Venkatesh Jeganathan
  • Isabel Casimiro
  • Celia F. Brosnan
  • Nicholas E. S. Sibinga
Research Article


Experimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS), is mediated by myelinspecific autoreactive T cells that cause inflammation and demyelination in the central nervous system (CNS), with significant contributions from activated microglia and macrophages. The molecular bases for expansion and activation of these cells, plus trafficking to the CNS for peripheral cells, are not fully understood. Allograft inflammatory factor-1 (Aif-1) (also known as ionized Ca2+ binding adapter-1 [Iba-1]) is induced in leukocytes in MS and EAE; here we provide the first assessment of Aif-1 function in this setting. After myelin oligodendrocyte glycoprotein peptide (MOG35–55) immunization, Aif-1-deficient mice were less likely than controls to develop EAE and had less CNS leukocyte infiltration and demyelination; their spinal cords contained fewer CD4 T cells and microglia and more CD8 T cells. These mice also showed significantly less splenic CD4 T-cell expansion and activation, plus decreased proinflammatory cytokine expression. These findings identify Aif-1 as a potent molecule that promotes expansion and activation of CD4 T cells, plus elaboration of a proinflammatory cytokine milieu, in MOG35–55-induced EAE and as a potential therapeutic target in MS.



We thank the staff of the Albert Einstein College of Medicine Analytical Imaging Facility, FACS and Histology core facilities of Albert Einstein College of Medicine for their expert assistance. This work was supported in part by Pilot Project PP1500 from the National Multiple Sclerosis Foundation and by grant HL67944 from the National Institutes of Health.

Supplementary material

10020_2015_2101233_MOESM1_ESM.pdf (1.1 mb)
Supplementary material, approximately 1.13 MB.


  1. 1.
    Frohman EM, Racke MK, Raine CS. (2006) Multiple sclerosis: the plaque and its pathogenesis. N. Engl. J. Med. 354:942–55.CrossRefGoogle Scholar
  2. 2.
    Martin R, McFarland HF. (1995) Multiple sclerosis: are HLA class I molecules involved in disease pathogenesis? Ann. Neurol. 38:137–9.CrossRefGoogle Scholar
  3. 3.
    Compston A, Coles A. (2008) Multiple sclerosis. Lancet. 372:1502–17.CrossRefGoogle Scholar
  4. 4.
    Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C. (1994) Animal models. Ann. Neurol. 36 (Suppl.):S47–53.CrossRefGoogle Scholar
  5. 5.
    Miller SD, Karpus WJ. (1994) The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:356–61.CrossRefGoogle Scholar
  6. 6.
    Langrish CL, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233–40.CrossRefGoogle Scholar
  7. 7.
    Zhang R, et al. (2011) Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance. J. Mol. Neurosci. 44:31–40.CrossRefGoogle Scholar
  8. 8.
    Steinman L, Zamvil SS. (2005) Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26:565–71.CrossRefGoogle Scholar
  9. 9.
    Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. (2010) Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One. 5:e15531.CrossRefGoogle Scholar
  10. 10.
    Napoli I, Neumann H. (2010) Protective effects of microglia in multiple sclerosis. Exp. Neurol. 225:24–8.CrossRefGoogle Scholar
  11. 11.
    Jiang Z, Jiang JX, Zhang GX. (2014) Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol. Lett. 160:17–22.CrossRefGoogle Scholar
  12. 12.
    Iris FJ, et al. (1993) Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat. Genet. 3:137–45.CrossRefGoogle Scholar
  13. 13.
    Deininger MH, Meyermann R, Schluesener HJ. (2002) The allograft inflammatory factor-1 family of proteins. FEBS Lett. 514:115–21.CrossRefGoogle Scholar
  14. 14.
    Autieri MV, Haines DS, Romanic AM, Ohlstein EH. (1996) Expression of 14-3-3 gamma in injured arteries and growth factor- and cytokinestimulated human vascular smooth muscle cells. Cell Growth Differ. 7:1453–60.PubMedGoogle Scholar
  15. 15.
    Hara H, et al. (1999) Isolation of two novel alternative splicing variants of allograft inflammatory factor-1. Biol. Chem. 380:1333–6.CrossRefGoogle Scholar
  16. 16.
    Del Galdo F, Jimenez SA. (2007) T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum. 56:3478–88.CrossRefGoogle Scholar
  17. 17.
    Kelemen SE, Autieri MV. (2005) Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am. J. Pathol. 167:619–26.CrossRefGoogle Scholar
  18. 18.
    Utans U, et al. (1996) Allograft inflammatory factory-1: a cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation. 61:1387–92.CrossRefGoogle Scholar
  19. 19.
    Zhao YY, Yan DJ, Chen ZW. (2013) Role of AIF-1 in the regulation of inflammatory activation and diverse disease processes. Cell. Immunol. 284:75–83.CrossRefGoogle Scholar
  20. 20.
    Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. (1998) Allograft-inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia. 24:244–51.CrossRefGoogle Scholar
  21. 21.
    Lu J, et al. (2012) Pain in experimental autoimmune encephalitis: a comparative study between different mouse models. J. Neuroinflammation. 9:233.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Watano K, et al. (2001) Allograft inflammatory factor-1 augments production of interleukin-6, −10 and −12 by a mouse macrophage line. Immunology. 104:307–16.CrossRefGoogle Scholar
  23. 23.
    Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. (2000) Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 113:3073–84.PubMedGoogle Scholar
  24. 24.
    Casimiro I, Chinnasamy P, Sibinga NE. (2013) Genetic inactivation of the allograft inflammatory factor-1 locus. Genesis. 51:734–40.CrossRefGoogle Scholar
  25. 25.
    Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies. (2011) Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press.Google Scholar
  26. 26.
    Lutz SE, Raine CS, Brosnan CF. (2012) Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice. J. Neuroimmunol. 245:8–14.CrossRefGoogle Scholar
  27. 27.
    Pfaffl MW. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.CrossRefGoogle Scholar
  28. 28.
    Steinman L. (1999) Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron. 24:511–4.CrossRefGoogle Scholar
  29. 29.
    Derecki NC, et al. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature. 484:105–9.CrossRefGoogle Scholar
  30. 30.
    Furtado GC, et al. (2008) Swift entry of myelinspecific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis. J. Immunol. 181:4648–55.CrossRefGoogle Scholar
  31. 31.
    O’Connor RA, et al. (2008) Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181:3750–4.CrossRefGoogle Scholar
  32. 32.
    Korn T, Mitsdoerffer M, Kuchroo VK. (2010) Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis. Results Probl. Cell Differ. 51:43–74.CrossRefGoogle Scholar
  33. 33.
    Cua DJ, et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744–8.CrossRefGoogle Scholar
  34. 34.
    Thakker P, et al. (2007) IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178:2589–98.CrossRefGoogle Scholar
  35. 35.
    Sasaki Y, Ohsawa K, Kanazawa H, Kohsaka S, Imai Y. (2001) Iba1 is an actin-cross-linking protein in macrophages/microglia. Biochem. Biophys. Res. Commun. 286:292–7.CrossRefGoogle Scholar
  36. 36.
    Imai Y, Kohsaka S. (2002) Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia. 40:164–74.CrossRefGoogle Scholar
  37. 37.
    Autieri MV, Kelemen SE, Wendt KW. (2003) AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ. Res. 92:1107–14.CrossRefGoogle Scholar
  38. 38.
    Heasman SJ, Ridley AJ. (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell. Biol. 9:690–701.CrossRefGoogle Scholar
  39. 39.
    Yamada M, Ohsawa K, Imai Y, Kohsaka S, Kamitori S. (2006) X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding. J. Mol. Biol. 364:449–57.CrossRefGoogle Scholar
  40. 40.
    Schulze JO, et al. (2008) Structural and functional characterization of human Iba proteins. FEBS J. 275:4627–40.CrossRefGoogle Scholar
  41. 41.
    Holsinger LJ, et al. (1998) Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563–72.CrossRefGoogle Scholar
  42. 42.
    Becart S, et al. (2008) Tyrosine-phosphorylation-dependent translocation of the SLAT protein to the immunological synapse is required for NFAT transcription factor activation. Immunity. 29:704–19.CrossRefGoogle Scholar
  43. 43.
    Kadoya M, et al. (2014) Allograft inflammatory factor-1 stimulates chemokine production and induces chemotaxis in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Comm. 448:287–91.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2015

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Prameladevi Chinnasamy
    • 1
    • 2
  • Sarah E. Lutz
    • 3
  • Dario F. Riascos-Bernal
    • 1
    • 2
  • Venkatesh Jeganathan
    • 4
  • Isabel Casimiro
    • 1
    • 2
  • Celia F. Brosnan
    • 3
  • Nicholas E. S. Sibinga
    • 1
    • 2
    • 5
  1. 1.Department of Medicine (Cardiovascular Division)Albert Einstein College of Medicine, Forchheimer G46BronxUSA
  2. 2.Department of Developmental and Molecular BiologyAlbert Einstein College of MedicineBronxUSA
  3. 3.Department of NeuroscienceAlbert Einstein College of MedicineBronxUSA
  4. 4.Center for Autoimmune and Musculoskeletal DiseaseThe Feinstein Institute of Medical ResearchManhassetUSA
  5. 5.Wilf Family Cardiovascular Research InstituteAlbert Einstein College of MedicineBronxUSA

Personalised recommendations